Cart
sales@molnova.com
Misonidazole
CAS No. 13551-87-6
Misonidazole( —— )
Catalog No. M27482 CAS No. 13551-87-6
Misonidazole as a novel GPX inhibitors to cause oxidative stress in chemotherapy-resistant tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 65 | In Stock |
|
| 2MG | 40 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 155 | In Stock |
|
| 50MG | 226 | In Stock |
|
| 100MG | 340 | In Stock |
|
| 200MG | 501 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMisonidazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionMisonidazole as a novel GPX inhibitors to cause oxidative stress in chemotherapy-resistant tumors.
-
DescriptionMisonidazole as a novel GPX inhibitors to cause oxidative stress in chemotherapy-resistant tumors.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCereblon|CDK4|CDK6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13551-87-6
-
Formula Weight201.18
-
Molecular FormulaC7H11N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOCC(Cn1c([N+]([O-])=O)ncc1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jian Jin, et al. Compositions and methods for treating cdk4/6-mediated cancer. WO2018106870A1.
molnova catalog
related products
-
Cucurbit
Cucurbit[7]uril is an emerging candidate for pharmaceutical excipients.Cucurbit[7]uril enhances photosensitization of porphyrins in Neuroblastoma cells.
-
Benzo[a]pyrene
Benzo[a]pyrene shows lung carcinogenicity in mice in a dose-dependent manner.
-
(S)-Leucic acid
Hydroxyisocaproic acid is an end product of leucine metabolism in human tissues such as muscle and connective tissue. It belongs to 2-hydroxycarboxylic acid group of amino acid metabolites. Hydroxyisocaproic acid functions as an “anti-catabolite” and is widely used in the bodybuilding community.
